Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest update is out from Integral Diagnostics Ltd. ( (AU:IDX) ).
Integral Diagnostics Limited has appointed Dr. Manish Mittal, a seasoned radiologist with significant experience in MRI and various radiological specializations, to its Board as a Radiologist Executive Director. This strategic appointment underscores IDX’s commitment to integrating specialist medical perspectives into its leadership, enhancing its operational and strategic decision-making processes.
More about Integral Diagnostics Ltd.
Integral Diagnostics (IDX) is a leading provider of medical imaging services across Australia and New Zealand, employing some of Australasia’s top radiologists and diagnostic imaging specialists. The company operates under a unique medical leadership model, ensuring quality patient care, service, and access.
YTD Price Performance: 2.75%
Average Trading Volume: 956,552
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$1.11B
See more insights into IDX stock on TipRanks’ Stock Analysis page.
